These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634 [TBL] [Abstract][Full Text] [Related]
24. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy. Rizik DG; Klassen KJ Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786 [TBL] [Abstract][Full Text] [Related]
25. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy. Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381 [TBL] [Abstract][Full Text] [Related]
26. Drug-eluting stents and antiplatelet resistance. Simon DI; Jozic J Am J Cardiol; 2008 Nov; 102(9 Suppl):29J-37J. PubMed ID: 18928790 [TBL] [Abstract][Full Text] [Related]
27. ST-elevation myocardial infarction caused by very late stent thrombosis due to drug-eluting stent fracture. Ma GT; Li L; Wu XH Chin Med J (Engl); 2012 Aug; 125(15):2794-6. PubMed ID: 22931998 [No Abstract] [Full Text] [Related]
28. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241 [TBL] [Abstract][Full Text] [Related]
29. Recurrent very late drug-eluting stent thrombosis. Pesarini G; Arieti M; Spadaro R; Vassanelli C; Ribichini F Cardiovasc Revasc Med; 2009; 10(2):130-5. PubMed ID: 19327678 [TBL] [Abstract][Full Text] [Related]
30. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
31. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Eisenberg MJ; Richard PR; Libersan D; Filion KB Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638 [TBL] [Abstract][Full Text] [Related]